Skip to main content
. 2020 May 13;217(7):e20192205. doi: 10.1084/jem.20192205

Figure S5.

Figure S5.

Endothelial KrasG12D or BrafV600E gain-of-function mutations aberrantly enhance expression of adherens junctional proteins. (A) Analysis of differentially regulated transcripts show expression changes in E11.5 BrafV600E F/+; Lyve1Cre livers (n = 3). (B) KEGG pathway gene set enrichment analysis (GSEA) of differentially regulated, identified transcripts in E11.5 BrafV600E F/+; Lyve1Cre livers (n = 3). NES, normalized enriched score. (C and D) Flt4 (green) and Pecam1 (red) coimmunofluorescent staining with Hoechst nuclear counterstain (blue) on sections of murine BrafV600E F/+; Lyve1Cre embryonic liver (C) and murine KrasG12D F/+; Lyve1Cre liver (D). Red arrows show increased Flt4 expression. E, embryonic day. Scale bars: 100 µm (top row) and 10 µm (bottom row). n = 3. Two independent experiments. (E and F) Genotyping tables of embryos derived from Mapk1F/+; KrasG12D F/+ mice (E) or Mapk1F/+; BrafV600E F/+ (F) mice crossed with Mapk1F/+; Lyve1Cre/+ mice. χ2 P values 0.262 (E) and 0.991 (F).